In conclusion, substantial differences between the impact of Metformin and Imeglimin on the two major suggested mechanisms driving Metformin‐induced lactic acidosis, complex I and mGPDH inhibition, were documented. The gene discussed is GPD2; the disease is lactic acidosis.